Rang-du-Fliers, France-based Intech, a contract manufacturer of orthopedic instruments and implants, has finalized a partnership with Frankfurt, Germany-based Montagu, a private equity firm.
Intech Finalizes Partnership With Montagu
1 min read Premium comments
#intechSecondary#montagu
Founded over 20 years ago, Intech manufactures the following orthopedic products: instruments, implants, cases, trays, and silicone handles. Its products are used in hip, knee, spine, and trauma surgery.
From concept development to product delivery, Intech serves medical device companies. It provides research and design services to enable medical device companies to develop complex instruments. Additionally, it has fabrication facilities across the globe, including locations in the United States, France, and Malaysia. This ensures that it can support medical device companies from prototyping to production. Per its press release, Intech is “determined to reach new heights in the industry, offering customers increased agility and responsiveness, all whilst maintaining its best-in-class customer experience.”
Montagu Director Adrien Sassi expressed excitement about the partnership stating, “We are excited to partner with Laurent [Pruvost] and his team in their mission to deliver unique solutions that improve patient outcomes worldwide. Intech represents a classic Montagu investment within an attractive market supported by long-lasting growth drivers.”
Montagu was founded over 50 years ago as a business providing risk capital to small businesses in the United Kingdom. It has evolved since its founding and now it partners with “high-quality businesses in stable and growing markets that provide products or services that would be ‘badly missed’ by their customers.”
In the press release, Intech President and CEO Laurent Pruvost commented, “I believe given Montagu’s expertise in healthcare and track-record in backing companies with similar business models to ours, makes them an ideal partner for Intech.”
Pruvost continued, “They will give us the tools to help our customers reduce manufacturing costs and time-to-market. Most importantly, they also share our passion for innovation and enhancing peoples’ lives.”
The companies’ management, Montagu, and Eurazeo (a Paris, France-based investment company) led the partnership negotiations. Now that it is complete, the companies will work to achieve Intech’s mission of “solving the most complex engineering challenges in the orthopedics industry, while positively impacting lives.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.